603439 Stock Overview
GuiZhou SanLi Pharmaceutical Co.,LTD. engages in the research and development, production, and marketing of pharmaceutical products. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 4/6 |
| Past Performance | 4/6 |
| Financial Health | 5/6 |
| Dividends | 3/6 |
My Notes
Capture your thoughts, links and company narrative
Guizhou Sanli Pharmaceutical Co.,Ltd Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥13.92 |
| 52 Week High | CN¥20.06 |
| 52 Week Low | CN¥10.69 |
| Beta | 0.82 |
| 1 Month Change | -0.57% |
| 3 Month Change | 16.68% |
| 1 Year Change | -23.89% |
| 3 Year Change | -8.66% |
| 5 Year Change | n/a |
| Change since IPO | 31.57% |
Recent News & Updates
Recent updates
We Ran A Stock Scan For Earnings Growth And Guizhou Sanli PharmaceuticalLtd (SHSE:603439) Passed With Ease
Oct 16
Little Excitement Around Guizhou Sanli Pharmaceutical Co.,Ltd's (SHSE:603439) Earnings
Aug 25Is Guizhou Sanli Pharmaceutical Co.,Ltd (SHSE:603439) Trading At A 20% Discount?
Aug 03Guizhou Sanli Pharmaceutical Co.,Ltd's (SHSE:603439) Intrinsic Value Is Potentially 73% Above Its Share Price
Apr 23Guizhou Sanli PharmaceuticalLtd (SHSE:603439) Seems To Use Debt Rather Sparingly
Mar 25Guizhou Sanli Pharmaceutical Co.,Ltd's (SHSE:603439) Price Is Right But Growth Is Lacking After Shares Rocket 26%
Mar 06Shareholder Returns
| 603439 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | -3.1% | -1.9% | -1.2% |
| 1Y | -23.9% | -1.8% | 11.8% |
Return vs Industry: 603439 underperformed the CN Pharmaceuticals industry which returned -1.8% over the past year.
Return vs Market: 603439 underperformed the CN Market which returned 11.8% over the past year.
Price Volatility
| 603439 volatility | |
|---|---|
| 603439 Average Weekly Movement | 6.3% |
| Pharmaceuticals Industry Average Movement | 7.4% |
| Market Average Movement | 8.7% |
| 10% most volatile stocks in CN Market | 12.8% |
| 10% least volatile stocks in CN Market | 5.7% |
Stable Share Price: 603439 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 603439's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1995 | 2,282 | Hai Zhang | www.gz-sanli.com |
GuiZhou SanLi Pharmaceutical Co.,LTD. engages in the research and development, production, and marketing of pharmaceutical products. It offers pediatric medication, respiratory system medication, cardiovascular drugs, injury by fall medication, rehabilitation medicine, GI medicine, and ophthalmic medicine.
Guizhou Sanli Pharmaceutical Co.,Ltd Fundamentals Summary
| 603439 fundamental statistics | |
|---|---|
| Market cap | CN¥5.57b |
| Earnings (TTM) | CN¥328.87m |
| Revenue (TTM) | CN¥2.11b |
16.9x
P/E Ratio2.6x
P/S RatioIs 603439 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 603439 income statement (TTM) | |
|---|---|
| Revenue | CN¥2.11b |
| Cost of Revenue | CN¥626.34m |
| Gross Profit | CN¥1.49b |
| Other Expenses | CN¥1.16b |
| Earnings | CN¥328.87m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.82 |
| Gross Margin | 70.35% |
| Net Profit Margin | 15.57% |
| Debt/Equity Ratio | 31.1% |
How did 603439 perform over the long term?
See historical performance and comparisonDividends
1.4%
Current Dividend Yield25%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/21 05:26 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Guizhou Sanli Pharmaceutical Co.,Ltd is covered by 6 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Yin Ye | Ping An Securities Co. Ltd. |
| Mengmeng Han | Ping An Securities Co. Ltd. |
| Ruibin Chen | Soochow Securities International Brokerage |